Two WUSTL students, both past winners of the university’s Olin Cup, have been chosen to participate in a nationally recognized year long program designed to accelerate the growth of high performance entrepreneurs.
Tom Cohen, PhD, post-doctoral research scholar at the School of Medicine and co-founder and CEO of Nanopore Diagnostics, and Amos Danielli, PhD, post-doctoral research scholar in biomedical engineering at the School of Engineering & Applied Science and founder of MagBiosense, are among this year’s class of Pipeline Fellows, as is WUSTL alumnus Alicia Herald (EMBA ’11), founder and CEO of myEDmatch.
Pipeline, based in Kansas City and founded by WUSTL alumnus Joni Cobb (JD ‘91), is an exclusive community of high-potential entrepreneurial leaders building high-growth companies throughout the Midwest region. Each year, approximately 12 new members representing the region’s top entrepreneurial companies are invited to join Pipeline after an extensive selection process.
New members from Kansas, Nebraska and Missouri participate in a yearlong business leadership development program focused on accelerating the growth of their companies. Pipeline blends workshop modules, advice from national experts and a deepening of the relationships among new and current Pipeline members.
“I’m honored and thrilled to have been chosen for this elite fellowship program,” said Cohen. “Pipeline has proven success in accelerating the growth of entrepreneurial companies. I’m looking forward to developing as an entrepreneur in the program this year and becoming a member of the Pipeline family.”
MagBiosense (LLC) is a medical device company developing a diagnostic device that can help emergency room clinicians reduce the time required to diagnose heart attacks by up to 70 percent. MagBiosense, then known as MMBiosensing, won the 2013 Olin Cup, sponsored by the Skandlaris Center for Entrepreneurial Studies.
About Nanopore Diagnostics
Nanopore Diagnostics is a molecular diagnostics company developing products that provide immediate, on-site, lab-quality molecular diagnostic testing. The microbial diagnostic test Nanopore Diagnostics is developing will help fight the spread of resistance by preventing the misuse of antibiotics. Nanopore Diagnostics won the 2014 Olin Cup.